Denali Therapeutics Inc. DNLI Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s common stock, par value (in dollars per share)?
- Denali Therapeutics Inc. (DNLI) reported common stock, par value (in dollars per share) of $0.01 in Q1 2026.
- How has Denali Therapeutics Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Denali Therapeutics Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.